NO20035599D0 - Deutererte N-substituerte og <alfa>-substituerte difenylalkoksyeddiksyreaminoalkylestere og medikamenter inneholdende disse - Google Patents

Deutererte N-substituerte og <alfa>-substituerte difenylalkoksyeddiksyreaminoalkylestere og medikamenter inneholdende disse

Info

Publication number
NO20035599D0
NO20035599D0 NO20035599A NO20035599A NO20035599D0 NO 20035599 D0 NO20035599 D0 NO 20035599D0 NO 20035599 A NO20035599 A NO 20035599A NO 20035599 A NO20035599 A NO 20035599A NO 20035599 D0 NO20035599 D0 NO 20035599D0
Authority
NO
Norway
Prior art keywords
substituted
alfa
deuterated
drugs containing
aminoalkyl esters
Prior art date
Application number
NO20035599A
Other languages
English (en)
Norwegian (no)
Inventor
Rudolf-Giesbert Alken
Johann Roither
Wolf-Dietrich Huebner
Werner Hrachowina
Thomas Stabingis
Original Assignee
Turicum Drug Dev Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Turicum Drug Dev Ag filed Critical Turicum Drug Dev Ag
Publication of NO20035599D0 publication Critical patent/NO20035599D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20035599A 2001-06-17 2003-12-16 Deutererte N-substituerte og <alfa>-substituerte difenylalkoksyeddiksyreaminoalkylestere og medikamenter inneholdende disse NO20035599D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10129832A DE10129832A1 (de) 2001-06-17 2001-06-17 Deuterierte N- und alpha-substituierte Diphenylalkoxyessigsäureaminoalkylester sowie diese Verbindungen enthaltende Arzneimittel
PCT/DE2002/002260 WO2002102743A2 (de) 2001-06-17 2002-06-17 Deuterierte n- und alpha-substituierte diphenylalkoyxessigsäureaminoalkylester sowie diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
NO20035599D0 true NO20035599D0 (no) 2003-12-16

Family

ID=7688891

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035599A NO20035599D0 (no) 2001-06-17 2003-12-16 Deutererte N-substituerte og <alfa>-substituerte difenylalkoksyeddiksyreaminoalkylestere og medikamenter inneholdende disse

Country Status (16)

Country Link
US (1) US20040242887A1 (de)
EP (1) EP1397327A2 (de)
JP (1) JP2004534802A (de)
KR (1) KR20040020926A (de)
CN (1) CN1516684A (de)
CA (1) CA2451638A1 (de)
CZ (1) CZ20033365A3 (de)
DE (1) DE10129832A1 (de)
HU (1) HUP0400213A3 (de)
IL (1) IL159410A0 (de)
IS (1) IS7061A (de)
NO (1) NO20035599D0 (de)
NZ (1) NZ530352A (de)
PL (1) PL367218A1 (de)
RU (1) RU2004101229A (de)
WO (1) WO2002102743A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080146573A1 (en) * 2006-12-04 2008-06-19 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted oxzolidinones
US20090209608A1 (en) * 2007-08-29 2009-08-20 Protia, Llc Deuterium-enriched asenapine
US20090062185A1 (en) * 2007-08-29 2009-03-05 Protia, Llc Deuterium-enriched anidulafungin
US20090069219A1 (en) * 2007-09-09 2009-03-12 Protia, Llc Deuterium-enriched telavancin
US20090076158A1 (en) * 2007-09-13 2009-03-19 Protia, Llc Deuterium-enriched bicalutamide
US20090075870A1 (en) * 2007-09-17 2009-03-19 Protia, Llc Deuterium-enriched caspofungin
US20090082419A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched tegaserod
AR075584A1 (es) 2009-02-27 2011-04-20 Intermune Inc COMPOSICIONES TERAPEUTICAS QUE COMPRENDEN beta-D-2'-DESOXI-2'-FLUORO-2'-C-METILCITIDINA Y UN DERIVADO DE ACIDO ISOINDOL CARBOXILICO Y SUS USOS. COMPUESTO.
US20120244122A1 (en) * 2009-05-28 2012-09-27 Masse Craig E Peptides for the Treatment of HCV Infections
KR20120110090A (ko) * 2009-09-28 2012-10-09 에프. 호프만-라 로슈 리미티드 Ｃ형 간염 바이러스 복제의 신규한 마크로시클릭 저해제
CN102584592B (zh) * 2011-12-28 2014-10-15 李进 一种氘代的拟除虫菊酯化合物及其制备方法和应用
CN104093707B (zh) * 2012-01-30 2016-01-06 大鹏药品工业株式会社 乙酸酯化合物或其盐
AU2013300009B2 (en) 2012-08-09 2017-06-15 Chase Pharmaceuticals Corporation Piperidinium quaternary salts
MY181470A (en) 2013-05-30 2020-12-22 Taiho Pharmaceutical Co Ltd Novel fluorinated benzilic acid ester compound and salt thereof
CN107445798B (zh) * 2016-06-01 2020-11-03 中国农业大学 一种α,α‐二氘代醇类化合物的合成方法
CN116078377B (zh) * 2023-03-06 2023-06-27 泽升科技(广州)有限公司 一种负载催化剂催化制备氘代苯的生产工艺

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD106642A1 (de) * 1973-03-02 1974-06-20
DD139212A1 (de) * 1978-10-09 1979-12-19 Christian Starke Verfahren zur herstellung eines neuen arzneimittels aus alpha,alpha-diphenyl-alpha-alkoxyessigsaeure-1-methylpiperidyl-4-ester-derivaten
JPS6439873A (en) * 1987-08-05 1989-02-10 Sharp Kk Synchronizing signal generating circuit
ES2122246T3 (es) * 1993-01-28 1998-12-16 Univ Iowa Res Found Sevoflurano deuterado como anestesico de inhalacion.
DE4343838C2 (de) * 1993-12-22 1998-07-09 Lohmann Therapie Syst Lts Deuteriertes Arzneimittel in transdermaler Applikation und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
JP2004534802A (ja) 2004-11-18
CA2451638A1 (en) 2002-12-27
NZ530352A (en) 2004-12-24
WO2002102743A9 (de) 2004-03-11
KR20040020926A (ko) 2004-03-09
US20040242887A1 (en) 2004-12-02
RU2004101229A (ru) 2005-06-27
WO2002102743A2 (de) 2002-12-27
DE10129832A1 (de) 2003-07-10
EP1397327A2 (de) 2004-03-17
HUP0400213A3 (en) 2005-08-29
HUP0400213A2 (hu) 2004-07-28
WO2002102743A3 (de) 2003-03-13
IS7061A (is) 2003-11-28
CZ20033365A3 (cs) 2004-09-15
CN1516684A (zh) 2004-07-28
IL159410A0 (en) 2004-06-01
PL367218A1 (en) 2005-02-21

Similar Documents

Publication Publication Date Title
NO20035599D0 (no) Deutererte N-substituerte og &lt;alfa&gt;-substituerte difenylalkoksyeddiksyreaminoalkylestere og medikamenter inneholdende disse
NO20012245D0 (no) Anthranilsyreamider og anvendelse derav som medikamenter
NO20020374L (no) Karboksylsyreamider, medikamenter inneholdende disse forbindelser, deres anvendelse og fremstilling
DE60026022D1 (de) Fluor enthaltende allylether und höhere homologe
NO20042906L (no) Deutererte, substituerte pyrazolybenzylsulfonamider og medikamenter som inneholder disse forbindelsene
DK1399153T3 (da) Farmaceutisk præparat indeholdende orlistat og en fedtsyre eller et salt deraf
IL219310A (en) Anti-micronucleic nucleic acid molecules and their pharmaceutical preparations
NO20041872L (no) Esterforbindelser og medisinsk anvendelse derav
DK1400518T3 (da) Heterocycliske forbindelser og lægemidler
HUP0303325A3 (en) Pharmaceutical salts and pharmaceutical compositions containing them
NO20001914L (no) &lt;alfa&gt;-akryl-N-alkylnitroner og farmasøytiske blandinger som inneholder slike
DK1534760T3 (da) Kvaterniserede polymerer med syreendegrupper og sammensætninger som indeholder disse
DK1354873T3 (da) Perindoaprilsalt og farmaceutiske sammensætninger indeholdende dette
NO20033854D0 (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
NO20042907L (no) Deutererte, substituerte dihydrofuranoner og medikamenter som inneholder disse forbindelsene
DE60217089D1 (de) Lipidsenkende biphenylcarbonsäureamide
IS7275A (is) Samsetning fyrir hollegg og notkun á henni
DK1572950T3 (da) Enkeltdomæne TDF-relaterede forbindelser og analoger deraf
NO20042137L (no) Antranilsyreamider og deres farmasoytiske anvendelse
NO20033709L (no) Medisinske preparater omfattende Diklofenak og Ornoprostil
DK1228026T3 (da) 15-Hydroxyicosatetraensyrerelaterede forbindelser og fremgangsmåde til anvendelse
NO20013816L (no) Benzamidderivater og legemidler som inneholder disse
NO20005164D0 (no) 2-metylpropionsyre-derivater og medisinske sammensetninger inneholdende det samme
NO20041729L (no) Et enantiomert rent opioid diarylmetylpiperazin og fremgangsmater for a anvende det samme
DK1187812T3 (da) Substituerede phenylcyclohexancarboxylsyreamider og deres anvendelse som adenosinoptagelses-inhibitorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application